Annual Meeting 2018

AHPPI Annual Meeting

Friday 22 June, 09.00 – 17.00

Church House, Westminster, London

We are pleased to present the programme for this year’s AHPPI Annual Meeting.



09:00 Arrival and Coffee
09:30 Welcome and opening remarks AHPPI
Morning Session Chaired by Prof James Ritter, Emeritus Professor of Clinical Pharmacology, Kings College London
09.45 Keynote speech Professor Alan Boyd, President of the Faculty of Pharmaceutical Medicine
10.25 Integrating adaptive pharmaceutical and clinical strategies to improve flexibility and efficiency in early development. Prof Peter Scholes, Chief Scientific Officer, Quotient Sciences
11:05 Tea/Coffee & Networking
11:35 Medical Imaging in early Phase Trials Dr Phillip Murphy; Head, Clinical Imaging, GlaxoSmithkline
12:15 The impact of the Revised EMA FIH guidelines on toxicity assessment and dose escalation Dr David Jones, Expert Pharmaco-Toxicologist, Clinical Trials Unit, MHRA
12:55 Lunch and networking
Afternoon Session Chaired by Dr Alan Houston, Vice President, European Head of Clinical Development at BioMarin Pharmaceutical Inc.
14:00 Early trials in Patients Charlotte Chadwick, Head of Early Phase Unit, MAC Research
14:40 Capitalising on our experience in the review of early phase clinical trials Catherine Blewett, HRA Improvement and Liaison Manager, Health Research Authority
15:20 Tea/Coffee & Networking
15:50 UK Clinical Trials Regulation – Challenges and Opportunities of the New CTR Dr Sam Bunce, Leeds University
16:30 Brexit and beyond: Ensuring the UK remains a great place to conduct clinical trials Dr Kirsty Wydenbach, Deputy Unit Manager / Senior Medical Assessor, Clinical Trials Unit, MHRA
17:10 Discussion and closing remarks AHPPI

The Faculty of Pharmaceutical Medicine has approved this event for CPD (6.5 points).

Eventbrite - AHPPI Annual Meeting - 2018

Please contact us with any questions at

Frontiers in Pharmacology have kindly offered to publish the proceedings of this meeting.

Niche Science and Technology Limited will prepare the manuscript.

We were delighted to be sponsored by Celerion, Quotient Sciences, PAREXEL and Richmond Pharmacology for this year’s meeting.

Comments are closed.